In a cramped, dimly lit consultation room at a peri-urban clinic outside Nairobi, twenty-four-year-old Samuel sits with his head in his hands. He is alarmingly thin, a physical manifestation of a decades-old developmental struggle that few doctors in the region were trained to recognize. For two years, he was treated for Type 1 diabetes, subjected to insulin regimens that did little to stabilize his glucose and often left him dizzy, nauseated, and dangerously weak. He is not alone Samuel is one of an estimated 25 million people globally—the vast majority residing in sub-Saharan Africa and Southeast Asia—who have been fighting a losing battle against a physiological reality that has only just begun to gain international medical recognition: Type 5 diabetes.

The formal recognition of Type 5 diabetes by the International Diabetes Federation (IDF) in early 2025 marked a watershed moment in global endocrinology. Historically, diabetes care has been binary: Type 1, the autoimmune failure of the pancreas and Type 2, the metabolic consequences of obesity and sedentary lifestyle. This rigid taxonomy has left millions of individuals in the Global South, like Samuel, in a diagnostic purgatory. Type 5, previously referred to as malnutrition-related diabetes mellitus (MRDM), is a distinct, non-autoimmune pathology caused by chronic undernutrition during critical developmental windows—fetal life, childhood, or adolescence—that stunts the growth of the pancreas and leaves it fundamentally unable to produce sufficient insulin.

The Misdiagnosis Trap

For decades, medical professionals in resource-constrained settings were forced to squeeze patients into the boxes of Type 1 or Type 2. The consequences of this misclassification are not merely administrative they are lethal. Patients with Type 5 are often lean, as the disease is born of deprivation, not excess. When they present with high blood glucose, clinicians—conditioned by Western medical protocols—often default to a Type 1 diagnosis, prescribing high doses of insulin. However, because Type 5 patients often retain some, albeit deficient, insulin production, high-dose insulin therapy can lead to severe hypoglycemia and profound metabolic instability.

• Prevalence: Estimated 25 million people worldwide affected, predominantly in low- and middle-income countries.
• Mechanism: Chronic early-life undernutrition impairs pancreatic development, resulting in irreversible insulin secretory defects.
• Diagnostic Risk: High incidence of misclassification as Type 1 or Type 2 due to physical presentation (low BMI).
• Clinical Paradox: Patients often require lower, more nuanced insulin doses or, in some cases, oral management, contrary to standard Type 1 protocols.

The Double Burden in East Africa

The rise of Type 5 diabetes in East Africa illuminates the "double burden of malnutrition"—a phenomenon where nations grapple simultaneously with the legacy of historical undernutrition and the modern, rapid onset of obesity-driven Type 2 diabetes. While urban centers in Nairobi are witnessing an explosion in lifestyle-related Type 2 cases among the emerging middle class, the peri-urban and rural peripheries are seeing a silent epidemic of Type 5. In these communities, the root cause is not an abundance of processed food, but the long-term, structural denial of the nutrients required for organogenesis during childhood.

Medical researchers at the University of Nairobi and health organizations across the region are now calling for a complete overhaul of screening protocols. The challenge, however, is immense. Kenya’s healthcare system remains heavily oriented toward the management of infectious diseases like malaria, HIV, and tuberculosis. Chronic non-communicable diseases are frequently deprioritized in funding cycles, and the specialized endocrine units required to differentiate between diabetes types are concentrated almost exclusively in major national referral hospitals, far beyond the reach of the rural poor.

The Economics of Metabolic Failure

The economic toll of this oversight is staggering. A young adult incapacitated by mismanaged diabetes represents a loss of human capital that a developing economy cannot sustain. When a productive citizen in their twenties is unable to work due to complications like vision loss, nerve damage, or kidney failure—all accelerated by years of misdiagnosis—the ripple effect extends to families and local communities. Current estimates suggest that the direct costs of managing the downstream complications of undiagnosed or mismanaged diabetes in sub-Saharan Africa consume a disproportionate share of limited household incomes.

Beyond the individual, the societal cost is equally concerning. The lack of standardized care protocols means that scarce resources are wasted on ineffective treatments. Developing a robust, locally specific diagnostic framework for Type 5 diabetes is not just a clinical imperative it is an economic necessity. This requires not only high-tech blood sugar monitoring but also a renewed focus on maternal health and childhood nutrition as primary preventive measures against metabolic disease.

A Path Toward Dignity

The official recognition of Type 5 diabetes provides a leverage point for advocates and policymakers. It forces the healthcare conversation to shift from purely biological outcomes to the socioeconomic determinants of health. If diabetes is a mirror reflecting the health of a society, then the rise of Type 5 diabetes in Africa is a mirror reflecting the persistent, damaging legacy of poverty and food insecurity. Addressing it requires more than just insulin it demands a fundamental commitment to ending the childhood nutritional deficits that sow the seeds of this disease years before the first symptoms ever appear. As medical boards begin to integrate this new knowledge into training modules for primary care physicians, the hope is that young patients will no longer be treated for a disease they do not have, but supported for the reality they actually face.

The era of treating every thin diabetic patient as a Type 1 case must end, for the sake of the millions who are currently living on the margins of an ignored epidemic.